API Pharma Service – End-to-End, Regulatory-Compliant, and Scalable API Manufacturing
As a Manufacturer & Solution Provider, Lianhe Aigen delivers integrated API Pharma Services, supporting global pharmaceutical companies from preclinical research to commercial API production.
Why API Pharma Service Matters
Active Pharmaceutical Ingredients (APIs) are the foundation of effective and safe therapeutics. Partnering with a reliable API Pharma Service provider ensures regulatory compliance, reproducible quality, and scalable manufacturing across all stages of development.
Lianhe Aigen provides comprehensive API Pharma Services, including:
-
Preclinical API supply for early-stage drug discovery
-
Clinical-stage API manufacturing for IND-enabling studies
-
Commercial-scale API production for global markets
As a trusted Manufacturer & Solution Provider, we integrate RSM, Drug Substance, and commercial API supply, delivering risk-controlled, high-quality, and scalable solutions.
Our services include:
Custom API Development: Tailored solutions for diverse therapeutic areas.
GMP Manufacturing: High-quality APIs produced in compliance with global standards.
Process Optimization: Cost-effective and sustainable production methods.
Analytical Expertise: Advanced tools for API characterization and quality control.
Choose Lianhe Aigen for reliable API production that meets the highest industry standards.
Our API Pharma Capabilities
Lianhe Aigen’s API Pharma Services include:
-
Preclinical API supply: supporting early-stage drug candidates with reproducible quality
-
Clinical-stage API manufacturing: scalable, controlled processes for clinical trials
-
Commercial-scale API production: reliable supply for regulatory-approved APIs
-
Process development & optimization: reproducible, risk-controlled manufacturing for complex molecules
-
Integrated CRDMO platform: seamless handover from RSM to Drug Substance to commercial APIs
Quality & Regulatory Compliance
Quality and compliance are central to our API Pharma Service:
-
Fully compliant with GxP regulations and ICH Q7 guidelines
-
Facilities successfully inspected by FDA, EMA, PMDA, TGA, KFDA, NMPA
-
Complete traceability of raw materials and intermediates
-
Robust change control and deviation management systems
-
Support for customer audits and regulatory filings
Our quality system ensures every batch is risk-controlled, consistent, and ready for regulatory submission.
Typical Project Scenarios
We deliver high-quality API manufacturing across project needs:
-
Preclinical-stage API supply for early drug candidates
-
Clinical-stage API manufacturing for IND-enabling studies
-
Commercial-scale API production for regulatory-approved APIs
-
Technology transfer and process scale-up for reproducible commercial manufacturing
Why Partner with Lianhe Aigen
As a Manufacturer & Solution Provider, Lianhe Aigen combines:
-
End-to-end CRDMO capabilities covering RSM, Drug Substance, and commercial API production
-
Proven record with FDA, EMA, PMDA, TGA, KFDA, NMPA inspections
-
Long-term, risk-controlled API supply for global pharmaceutical clients
-
Experienced team in process development, quality assurance, and regulatory compliance
Partnering with Lianhe Aigen ensures your API supply chain is robust, compliant, and capable of supporting critical projects from preclinical to commercial stages.
Accelerate your projects with a trusted API Pharma Service provider, delivering preclinical to commercial API manufacturing.
